Outcome Reporting Bias in Antipsychotic Medication Trials
A new study in the journal Translational Psychiatry, an influential journal in biological psychiatry published by Nature, challenges the state of the research on antipsychotic drugs.
RAISE Study Out Of Sync With Media Reports
Writing on his 1 Boring Old Man blog, Dr. Mickey Nardo reflects on the media frenzy around the RAISE study and asks why the prescription data has not been released. He adds skepticism about the political motives of the potentially overblown results, which he sees as a clear push for increased mental health funding.
Claims That Long-term Antipsychotic Use Leads to Better Outcomes are Misleading, Researchers Argue
Researchers reveal the limitations and misleading interpretations of two recent studies that claim to demonstrate that long-term antipsychotic use leads to better outcomes.
NIMH: RAISE Study to Have Immediate Clinical Impact
In a Science Update, the National Institute of Mental Health (NIMH) reports that Medicaid services is already taking steps to implement “coordinated specialty care” (CSC) in response to the RAISE study released last week. “The RAISE initiative has shown that coordinated specialty care for first episode psychosis is better than the standard care offered in community clinics. However, covering the cost of coordinated specialty care can be challenging. When Medicaid agrees to pay for effective treatment programs, patients in need benefit.”
Researchers Explore Sexuality and Gender in the Context of Psychosis
Nev Jones and a team of researchers examine how sex, sexuality, and gender-related content are underexplored in contemporary research on psychosis.
Children with ‘ADHD’ Commonly Prescribed Antipsychotics
Despite little evidence for benefit, and substantial risk of harm, antipsychotics are commonly prescribed to children diagnosed with ADHD
Adderall Use Associated with Increased Risk of Psychosis
Twice as many teenagers with ADHD experienced severe psychosis when taking Adderall, as compared to Ritalin, according to a new study.
Markingson Case Supporters: Please Join Our Call-In Campaign
Patient advocates and bioethicists have launched a call-in campaign demanding action on psychiatric research abuse at the University of Minnesota.
Study Examines Women’s Experiences of Hearing Voices
An international group of researchers from multiple disciplines has published a historical, qualitative, and quantitative investigation into voice-hearing in women. The interdisciplinary project, freely available from Frontiers in Psychiatry, explores how sexism, exploitation, and oppression bear on women’s’ experiences of hearing voices.
Family Oriented, Home-Based Treatment Best for Youth with Symptoms of Psychosis
A pathbreaking new study out of Finland suggests that early intervention programs for youth experiencing psychotic-like symptoms may see the greatest improvement when treatment works within the home rather than in a hospital setting. The research, to be published in next month’s issue of Psychiatry Research, found greater improvement in functioning, depression, and hopelessness among teens in a new need-adapted Family and Community oriented Integrative Treatment Model (FCTM) program.
Zel Dolinsky: I Have a Right to “Death With Dignity”
Researcher Zel Dolinsky once taught at medical school and worked as a medical writer in the pharmaceutical industry. In his last emails, he told of how the adverse effects of psychiatric drugs led him to choose to end his life.
I Want Change
Only two hours after we got home, Dan fearlessly told me of the suicide plan that he'd devised while in the hospital. He had all that time to think about it while nobody was listening. He'd lost his dignity, his identity and his place in society. He had lost the will to live.
CAFÉ Study: Real Science or Marketing Exercise?
I received the following question from a reader regarding the controversial CAFÉ – Comparisons of Atypicals in First Episode of Psychosis - study. (This was the study in which Dan Markingson committed suicide.) "It appears that there was no head-to-head with a control group taking a placebo pill. Nor was there a control group featuring 'old' types of 'antipsychotic'. If that was the case then it is very poor study . . . what on earth can you hope to show from the data?" I started to write a response, but the subject is complex, and my response became the following article.
New Research on Patient-Centered Deprescribing for Antipsychotics
Researchers review the risks and benefits of deprescribing from antipsychotic drugs and advocate for a patient-centered approach to tapering.
Sodium Nitroprusside Shows No Efficacy in Schizophrenia Treatment
Researchers question biases of preliminary trials that found that sodium nitroprusside, an antihypertensive drug, has positive effects on schizophrenia symptoms.
On “Schizophrenia”
The first time I heard someone labeled schizophrenic I was about 10 years old. A man was talking to himself and appeared to be house-less and perhaps on drugs. My mom, a very good teacher and explainer of things to me, said, “That man is schizophrenic. That means he can't tell the difference between what's inside of himself and what's outside.” In retrospect this seems like a relatively sophisticated and sensitive explanation; Falling in love, hearing music that enters our heart, having children/giving birth, connecting powerfully with another person in a meeting of the minds, feeling empathy, deeply caring about something, experiencing oneness with nature, are all examples of times when the line between inner and outer reality is blurred.
New Study Investigates Cannabidiol (CBD) for Psychosis
A new study examines the effects of CBD as an adjunct therapy to antipsychotic medication for patients diagnosed with schizophrenia.
Omega-3 Screening for Psychiatric Symptoms?
There is a substantial body of evidence suggesting that not getting enough omega-3 fatty acids in your diet may be connected to a diverse array of psychiatric symptoms. In a new study published this month, psychiatrist Robert McNamara and Erik Messamore provide an overview of the evidence and call for screening of omega-3 deficiency in people experiencing symptoms associated with ADHD, depression, mood disorders, and psychosis.
AVATAR Therapy Shows Some Positive Outcomes, Now What?
In a commentary piece, Ben Alderson-Day and Nev Jones discuss the AVATAR therapy research for psychosis and propose further questions.
Weak Field Trials Scuttle DSM-5 Diagnoses
"Mixed anxiety-depressive disorder," "attenuated psychosis syndrome," "obsessive-compulsive personality disorder," "antisocial personality disorder," and "nonsuicidal self-injury" were among diagnoses that met with disappointing results in...
In Chronic Patients, Antipsychotics Have Limited Efficacy in Reducing Symptoms
A large review and meta-analysis of 167 studies across 60 years dissects placebo-controlled randomized controlled trials of antipsychotic drugs.
The Role of Racial Bias in the Overdiagnosis of Schizophrenia
Researchers detect disparity between white and African American patients diagnosed with schizophrenia when symptoms of a mood disorder are present.
Non-Pharmacological Interventions More Effective For Health in Schizophrenia
Review compares the effectiveness of pharmacological and non-pharmacological interventions for improving physical health outcomes in people diagnosed with schizophrenia.
Study Explores Correlates of Low-Level Physical Activity and Psychosis
A study examines the variables correlated with low levels of physical activity in persons diagnosed with psychosis in low and middle-income countries
What Happens When Paranoid Feelings that You’re Being Watched are Correct?
McGill News reviews the new book Suspicious Minds: How Culture Shapes Madness, and discusses its themes with co-author McGill Canada Research Chair in Philosophy...